Results: 792
Lidocaine could promote the cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cells.
- Published in:
- BMC Cancer, 2025, v. 25, p. 1, doi. 10.1186/s12885-025-13533-1
- By:
- Publication type:
- Article
Corrigendum: A new variant of the ectodysplasin A receptor death domain gene associated with anhidrotic ectodermal dysplasia in a Turkish family and its simple diagnosis by restriction fragment length polymorphism.
- Published in:
- Genes & Genetic Systems, 2024, v. 99, p. i, doi. 10.1266/ggs.corrigendum_22-00138
- Publication type:
- Article
PD-1 / PD-L1 抑制剂治疗非小细胞肺癌并发免疫 相关不良反应预测模型的构建与验证.
- Published in:
- Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2024, v. 24, n. 12, p. 1449, doi. 10.14009/j.issn.1672-2124.2024.12.008
- By:
- Publication type:
- Article
The anti-melanoma roles and mechanisms of tricholoma isoflavone derivative CA028.
- Published in:
- NPJ Science of Food, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41538-025-00370-6
- By:
- Publication type:
- Article
Bacterial pathogenesis: A sweet interaction with death for EPEC.
- Published in:
- Nature Reviews Microbiology, 2013, v. 11, n. 10, p. 659, doi. 10.1038/nrmicro3127
- By:
- Publication type:
- Article
Immune evasion: UL141 keeps HCMV in charge.
- Published in:
- Nature Reviews Microbiology, 2013, v. 11, n. 5, p. 297, doi. 10.1038/nrmicro3018
- By:
- Publication type:
- Article
Fermented Brown Rice Extract Causes Apoptotic Death of Human Acute Lymphoblastic Leukemia Cells via Death Receptor Pathway.
- Published in:
- Applied Biochemistry & Biotechnology, 2016, v. 178, n. 8, p. 1599, doi. 10.1007/s12010-015-1970-y
- By:
- Publication type:
- Article
Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 329, doi. 10.1007/s00280-023-04613-9
- By:
- Publication type:
- Article
NCTR25 fusion facilitates the formation of TRAIL polymers that selectively activate TRAIL receptors with higher potency and efficacy than TRAIL.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 289, doi. 10.1007/s00280-021-04283-5
- By:
- Publication type:
- Article
Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of the potential for QTc prolongation in patients with solid tumors receiving nivolumab.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody targeting the DR5 receptor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 887, doi. 10.1007/s00280-015-2712-0
- By:
- Publication type:
- Article
Death receptor 5 agonistic antibody PRO95780: preclinical pharmacokinetics and concentration-effect relationship support clinical dose and regimen selection.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 405, doi. 10.1007/s00280-013-2200-3
- By:
- Publication type:
- Article
5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 195, doi. 10.1007/s00280-011-1686-9
- By:
- Publication type:
- Article
Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 3, p. 733, doi. 10.1007/s00280-010-1544-1
- By:
- Publication type:
- Article
SAC-TRAIL, a novel anticancer fusion protein: expression, purification, and functional characterization.
- Published in:
- Applied Microbiology & Biotechnology, 2022, v. 106, n. 4, p. 1511, doi. 10.1007/s00253-022-11807-3
- By:
- Publication type:
- Article
Anticancer potentiality and mode of action of low-carbohydrate proteins and peptides from mushrooms.
- Published in:
- Applied Microbiology & Biotechnology, 2020, v. 104, n. 16, p. 6855, doi. 10.1007/s00253-020-10707-8
- By:
- Publication type:
- Article
Cinobufagin: a promising therapeutic agent for cancer.
- Published in:
- Journal of Pharmacy & Pharmacology, 2023, v. 75, n. 9, p. 1141, doi. 10.1093/jpp/rgad059
- By:
- Publication type:
- Article
Anti-tumor effects of Thymus Caramanicus Jalas extract in mice through oxidative stress, inflammation and apoptosis.
- Published in:
- Journal of Pharmacy & Pharmacology, 2022, v. 74, n. 12, p. 1797, doi. 10.1093/jpp/rgac060
- By:
- Publication type:
- Article
Natural substances derived from herbs or plants are promising sources of anticancer agents against colorectal cancer via triggering apoptosis.
- Published in:
- Journal of Pharmacy & Pharmacology, 2022, v. 74, n. 2, p. 162, doi. 10.1093/jpp/rgab130
- By:
- Publication type:
- Article
Induction of the endogenous sialoglycan ligand for eosinophil death receptor Siglec-8 in chronic rhinosinusitis with hyperplastic nasal polyposis.
- Published in:
- Glycobiology, 2021, v. 31, n. 8, p. 1026, doi. 10.1093/glycob/cwab018
- By:
- Publication type:
- Article
Mathematical Modeling Reveals the Importance of the DED Filament Composition in the Effects of Small Molecules Targeting Caspase-8/c-FLIP<sub>L</sub> Heterodimer.
- Published in:
- Biochemistry (00062979), 2020, v. 85, n. 10, p. 1134, doi. 10.1134/S0006297920100028
- By:
- Publication type:
- Article
A New Efficient Method for Production of Recombinant Antitumor Cytokine TRAIL and Its Receptor-Selective Variant DR5-B.
- Published in:
- Biochemistry (00062979), 2019, v. 84, n. 6, p. 627, doi. 10.1134/S0006297919060051
- By:
- Publication type:
- Article
The Case Back on the TRAIL: Death Receptors as Markers for rhTRAIL Sensitivity.
- Published in:
- Journal of Applied Laboratory Medicine, 2017, p. 176, doi. 10.1373/jalm.2017.023408
- By:
- Publication type:
- Article
Efficient Drug Delivery and Induction of Apoptosis in Colorectal Tumors Using a Death Receptor 5-Targeted Nanomedicine.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 12, p. 2083, doi. 10.1038/mt.2014.137
- By:
- Publication type:
- Article
2A Peptide-based, Lentivirus-mediated Anti-death Receptor 5 Chimeric Antibody Expression Prevents Tumor Growth in Nude Mice.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 1, p. 46, doi. 10.1038/mt.2011.197
- By:
- Publication type:
- Article
Nanobodies targeting the interaction interface of programmed death receptor 1 (PD-1)/PD-1 ligand 1 (PD-1/PD-L1).
- Published in:
- Preparative Biochemistry & Biotechnology, 2020, v. 50, n. 3, p. 252, doi. 10.1080/10826068.2019.1692217
- By:
- Publication type:
- Article
ALTERED APOPTOSIS AND BIOTRANSFORMATION SIGNALING IN HCT-116 COLORECTAL CARCINOMA CELLS INDUCED BY Teucrium chamaedrys L. EXTRACT.
- Published in:
- Kragujevac Journal of Science, 2019, n. 41, p. 77, doi. 10.5937/kgjsci1941077m
- By:
- Publication type:
- Article
Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated Neisseria gonorrhoeae Microparticle Vaccine Formulation.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10070983
- By:
- Publication type:
- Article
Dual immune checkpoints inhibition: Cancer treatment and immunological modes of action.
- Published in:
- Journal of Drug Delivery & Therapeutics, 2023, v. 13, n. 6, p. 175, doi. 10.22270/jddt.v13i6.5880
- By:
- Publication type:
- Article
Regulation of death receptor-induced apoptosis induced via CD95/Fas and other death receptors.
- Published in:
- Molecular Biology, 2011, v. 45, n. 1, p. 150, doi. 10.1134/S0026893311010079
- By:
- Publication type:
- Article
Expression of Apoptosis, Autophagy and Necroptosis Effectors in Rat Hippocampal Cells after Excessive Fluoride Intake.
- Published in:
- Journal of Evolutionary Biochemistry & Physiology, 2024, v. 60, n. 5, p. 1772, doi. 10.1134/S0022093024050107
- By:
- Publication type:
- Article
Endoplasmic reticulum stress participates in apoptosis of HeLa cells exposed to TPHP and OH-TPHP via the eIF2α-ATF4/ATF3-CHOP-DR5/P53 signaling pathway.
- Published in:
- Toxicology Research, 2023, v. 12, n. 6, p. 1159, doi. 10.1093/toxres/tfad110
- By:
- Publication type:
- Article
Enhancement of anti-PD-L1 antibody plus anlotinib efficacy due to downregulation of PD-L1 in the micro-conduit endothelium within the tumor: a randomized double-blind trial.
- Published in:
- Cancer Biology & Medicine, 2024, v. 21, n. 10, p. 951, doi. 10.20892/j.issn.2095-3941.2023.0423
- By:
- Publication type:
- Article
CD13 inhibition augments DR4-induced tumor cell death in a p-ERK1/2-independent manner.
- Published in:
- Cancer Biology & Medicine, 2021, v. 18, n. 2, p. 569, doi. 10.20892/j.issn.2095-3941.2020.0196
- By:
- Publication type:
- Article
Grafting TRAIL through Either Amino or Carboxylic Groups onto Maghemite Nanoparticles: Influence on Pro-Apoptotic Efficiency.
- Published in:
- Nanomaterials (2079-4991), 2021, v. 11, n. 2, p. 502, doi. 10.3390/nano11020502
- By:
- Publication type:
- Article
Response of Tonsil Follicular Dendritic Cell Sarcoma to Multimodal Treatment Including Pembrolizumab: A Case Report and Literature Review.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.731175
- By:
- Publication type:
- Article
LCT-3d Induces Oxidative Stress-Mediated Apoptosis by Upregulating Death Receptor 5 in Gastric Cancer Cells.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.658608
- By:
- Publication type:
- Article
Corrigendum: GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
TLR4 signalling in ischemia/reperfusion injury: a promising target for linking inflammation, oxidative stress and programmed cell death to improve organ transplantation outcomes.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1447060
- By:
- Publication type:
- Article
Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1180997
- By:
- Publication type:
- Article
Programmed cell death-ligand 2: new insights in cancer.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1359532
- By:
- Publication type:
- Article
NK cell exhaustion in the tumor microenvironment.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1303605
- By:
- Publication type:
- Article
Nyctanthes arbor-tristis alkaloids activates p53 independent cell death receptor and necroptosis pathways in HepG2 cells.
- Published in:
- 3 Biotech, 2023, v. 13, n. 6, p. 1, doi. 10.1007/s13205-023-03594-z
- By:
- Publication type:
- Article
Nyctanthes arbor-tristis alkaloids activates p53 independent cell death receptor and necroptosis pathways in HepG2 cells.
- Published in:
- 3 Biotech, 2023, v. 13, n. 6, p. 1, doi. 10.1007/s13205-023-03594-z
- By:
- Publication type:
- Article
Phosphoproteome profiling uncovers a key role for CDKs in TNF signaling.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26289-6
- By:
- Publication type:
- Article
Efficacy of FRO on Acne Vulgaris Pathogenesis.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 7, p. 1885, doi. 10.3390/pharmaceutics15071885
- By:
- Publication type:
- Article
Novel Anticancer Strategies II.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 605, doi. 10.3390/pharmaceutics15020605
- By:
- Publication type:
- Article
Recent Advances in the Development of Nanodelivery Systems Targeting the TRAIL Death Receptor Pathway.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 515, doi. 10.3390/pharmaceutics15020515
- By:
- Publication type:
- Article